LOUIS LAZZARA: Open Payments
NPI 1558786186 · BUTLER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 18 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $519
Food & beverage: $296Education: $223
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $298 |
| Alkermes, Inc. | 6 | $111 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: ARISTADA, AUSTEDO XR, LYBALVI, UZEDY, INGREZZA, ABILIFY MAINTENA, REXULTI, COBENFY.
Industry payments across PA — which companies pay providers there.
